Evidence map›Paper›PMID 34184729›Full record

ArticleBiology open2021

Auxin treatment increases lifespan in Caenorhabditis elegans.

Julia A Loose, Arjumand Ghazi

Open access · goldAbstract read
In one paragraph

Article in Biology open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. microPublication biology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. New Roles for MicroRNAs in Old Worms.Frontiers in aging · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Julia A LooseDepartment of Pediatrics, University of Pittsburgh School of Medicine, Rangos Research Center, Children's Hospital of Pittsburgh, 15224 PA, USA.ORCID 0000-0001-6226-9177
Arjumand GhaziDepartment of Pediatrics, University of Pittsburgh School of Medicine, Rangos Research Center, Children's Hospital of Pittsburgh, 15224 PA, USA.ORCID 0000-0002-5859-4206
University of Pittsburgh · US

Funding

The Coordination of Lipid Synthesis and Breakdown in Metabolism and AgingR01AG051659 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GHAZI, ARJUMAND · 2016 to 2019
$1.6M
Role of the transcription elongation and splicing factor TCER-1 in repressing immunity and promoting fertilityR56AG066682 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GHAZI, ARJUMAND · 2021 to 2021
$321k
NIA NIH HHS R01 AG051659NIA NIH HHS R56 AG066682NIH HHS R01AG051659
6 · The paper itself

Abstract

The auxin-inducible degradation system (AID) has proven to be a highly versatile technology for rapid, robust and reversible depletion of proteins in multiple model systems. In recent years, AID has been adapted into the nematode Caenorhabditis elegans as a tool for conditional protein knockdown. Numerous transgenic strains have been created that, upon auxin exposure, undergo protein inactivation in the worm germline or somatic tissues, both during development and in young adults. Since longevity assays often involve long-term gene- and protein-manipulation, the facility for spatiotemporally precise and extended protein removal makes AID a potentially highly valuable tool for aging biology. However, whether auxins themselves impact worm longevity has not been directly addressed. Here, we show that prolonged exposure to indole 3-acetic acid (IAA), the auxin used in worm AID studies, extends lifespan. We also report that two transgenic strains expressing Arabidopsis proteins that are key components of the AID platform are longer lived than wild-type animals. Together, our results highlight the necessity for exercising caution while utilizing AID for longevity studies and in interpreting the resulting data. This article has an associated First Person interview with the first author of the paper.

Indexed as

AgingAnimalsAnimals, Genetically ModifiedCaenorhabditis elegansDose-Response Relationship, DrugGerm CellsHumansIndoleacetic AcidsLongevityProteolysisStress, PhysiologicalIndoleacetic AcidsAgingAuxinCaenorhabditis elegansLifespanProtein degradationStress

Identifiers

PMID34184729
PMCPMC8186727
OpenAlexW3160438818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.